These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17065065)

  • 1. Hypoxanthine effect on equilibrative and concentrative adenosine transport in human lymphocytes: implications in the phatogenesis of Lesch-Nyhan syndrome.
    Prior C; Torres RJ; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1065-9. PubMed ID: 17065065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxanthine decreases equilibrative type of adenosine transport in lymphocytes from Lesch-Nyhan patients.
    Prior C; Torres RJ; Puig JG
    Eur J Clin Invest; 2007 Nov; 37(11):905-11. PubMed ID: 17883419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hypoxanthine on adenosine transport in human lymphocytes. Implications in the pathogenesis of Lesch-Nyhan syndrome.
    Torres RJ; DeAntonio I; Prior C; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1177-9. PubMed ID: 15571225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine transport in HPRT deficient lymphocytes from Lesch-Nyhan disease patients.
    Torres RJ; DeAntonio I; Prior C; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1193-6. PubMed ID: 15571229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine transport in peripheral blood lymphocytes from Lesch-Nyhan patients.
    Torres RJ; Deantonio I; Prior C; Puig JG
    Biochem J; 2004 Feb; 377(Pt 3):733-9. PubMed ID: 14572307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients.
    García MG; Puig JG; Torres RJ
    Brain Behav Immun; 2009 Nov; 23(8):1125-31. PubMed ID: 19635551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the adenosinergic system in the brain of HPRT knockout mouse (Lesch-Nyhan disease).
    Bertelli M; Cecchin S; Lapucci C; Jacomelli G; Jinnah HA; Pandolfo M; Micheli V
    Clin Chim Acta; 2006 Nov; 373(1-2):104-7. PubMed ID: 16793031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the implication of hypoxanthine excess in the physiopathology of Lesch-Nyhan disease.
    Torres RJ; Prior C; Garcia MG; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):507-516. PubMed ID: 27906640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxanthine effects on cyclic AMP levels in human lymphocytes.
    Torres RJ; DeAntonio I; Prior C; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1181-3. PubMed ID: 15571226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
    Wu CL; Melton DW
    Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine metabolism in permanent lymphocyte lines and in erythrocytes of patients with the Lesch-Nyhan syndrome.
    Reem GH
    Adv Exp Med Biol; 1977; 76A():384-90. PubMed ID: 855718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients.
    Torres RJ; Prior C; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1077-82. PubMed ID: 17065067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiopathology of neurological signs of hypoxanthine-guanine phosphoribosyltransferase deficiency].
    Torres-Jiménez R; Mateos-Antón F; Arcas-Martínez J; Pascual-Castroviejo I; García-Puig J
    Rev Neurol; 1998 Dec; 27(160):1050-4. PubMed ID: 9951034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lesch-Nyhan syndrome: evidence for abnormal adrenergic function.
    Rockson S; Stone R; Van der Weyden M; Kelley WN
    Science; 1974 Dec; 186(4167):934-5. PubMed ID: 4469689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of the Lesch-Nyhan syndrome: ATP use is positively related to hypoxanthine supply to hypoxanthine guanine phosphoribosyltransferase.
    Harkness RA; McCreanor GM; Greenwood R
    J Inherit Metab Dis; 1991; 14(2):202-14. PubMed ID: 1886405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered membrane NTPase activity in Lesch-Nyhan disease fibroblasts: comparison with HPRT knockout mice and HPRT-deficient cell lines.
    Pinto CS; Jinnah HA; Shirley TL; Nyhan WL; Seifert R
    J Neurochem; 2005 Jun; 93(6):1579-86. PubMed ID: 15935074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new form of the Lesch-Nyhan syndrome. A study of hypoxanthine-guanine-phosphoribosyl-transferase in fibroblasts. The in vitro and in vivo effect of adenine on enzyme activity].
    Warter S; Bieth R
    Ann Biol Clin (Paris); 1982; 40(5):561-6. PubMed ID: 6186166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxanthine deregulates genes involved in early neuronal development. Implications in Lesch-Nyhan disease pathogenesis.
    Torres RJ; Puig JG
    J Inherit Metab Dis; 2015 Nov; 38(6):1109-18. PubMed ID: 25940910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of blood transfusion on activities of hypoxanthineguanine phosphoribosyltransferase (E.C.2.4.2.8.) and adenine phosphoribosyltransferase (E.C.2.4.2.7.) in cirulating red blood cells of a patient with Lesch-Nyhan syndrome.
    Pawlak AL; Zaremba JS; Barankiewicz J; Zdzienicka E; Czartoryska B
    Acta Med Pol; 1978; 19(3):331-6. PubMed ID: 735873
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the severity of hypoxanthine-guanine phosphoribosyltransferase deficiency using viable T cells.
    Yamanaka H; Kamatani N; Nishoka K; Kobayashi M; Wada Y; Ohtani T; Mikanagi K
    Hum Hered; 1985; 35(6):358-63. PubMed ID: 3876977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.